Bellecapital International Ltd. Sanofi Transaction History

Bellecapital International Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 16, 2020	SELL	$49.47 - $53.77 $270,848 - $294,390	-5,475 Closed	0 $0
Q2 2020 Jul 16, 2020	SELL	$42.91 - $52.5 $67,583 - $82,687	-1,575 Reduced 22.34%	5,475 $279,000
Q1 2020 Apr 24, 2020	SELL	$38.02 - $51.66 $76,040 - $103,320	-2,000 Reduced 22.1%	7,050 $308,000
Q1 2019 Apr 23, 2019	BUY	$40.83 - $45.43 $33,684 - $37,479	825 Added 10.03%	9,050 $401,000
Q4 2018 Feb 07, 2019	BUY	$41.48 - $45.59 $341,173 - $374,977	8,225 New	8,225 $357,000
Q3 2018 Oct 12, 2018	SELL	$40.0 - $44.84 $293,600 - $329,125	-7,340 Closed	0 $0
Q3 2017 Oct 25, 2017	BUY	$47.04 - $50.34 $345,273 - $369,495	7,340	7,340 $365,000

822

268M

1.9M

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $120B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

Get notified when there are updates to the investment portfolio of Bellecapital International Ltd., based on Form 13F filings with the SEC.

Stay updated on Bellecapital International Ltd. with notifications on news.